RHYTHM PHARMACEUTICALS, INC. Annual Operating Income (Loss) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Rhythm Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2023.
  • Rhythm Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$43.9M, a 0.16% increase year-over-year.
  • Rhythm Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$266M, a 43.4% decline year-over-year.
  • Rhythm Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$184M, a 2.9% decline from 2022.
  • Rhythm Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$179M, a 5.35% decline from 2021.
  • Rhythm Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$170M, a 24.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$184M -$5.2M -2.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$179M -$9.1M -5.35% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$170M -$33.5M -24.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 -$137M +$9.43M +6.46% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 -$146M -$67.6M -86.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$78.4M -$46M -142% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 -$32.4M -$6.51M -25.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 -$25.9M -$15.3M -145% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-08
2015 -$10.6M Jan 1, 2015 Dec 31, 2015 8-K 2018-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.